LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.

Autor: Mishra R; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Thunuguntla P; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Perkin A; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Duraiyan D; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Bagwill K; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Gonzales S; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Brizuela V; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Daly S; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Chang YJ; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Abebe M; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Rajana Y; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Wichmann K; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Bolick C; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., King J; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Fiala M; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101.; Siteman Cancer Center, Washington University in St. Louis, MO, 631102., Fortier J; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Jayasinghe R; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101., Schroeder M; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101.; Siteman Cancer Center, Washington University in St. Louis, MO, 631102., Ding L; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101.; Siteman Cancer Center, Washington University in St. Louis, MO, 631102., Vij R; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101.; Siteman Cancer Center, Washington University in St. Louis, MO, 631102., Silva-Fisher J; Department of Internal Medicine, Division of Oncology, School of Medicine, Washington University in St. Louis, MO, 631101.; Siteman Cancer Center, Washington University in St. Louis, MO, 631102.

Publikováno v: Research square [Res Sq] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.